This inventor holds 1 USPTO granted patent. Top assignee: Korea Advanced Institute of Science and Technology. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kyu-Min Han: Innovator in Stem Cell Research
Introduction
Kyu-Min Han is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of stem cell research, particularly in relation to cardiofaciocutaneous syndrome. His innovative work has the potential to advance our understanding of neural development in this condition.
Latest Patents
Kyu-Min Han holds a patent for an "Induced pluripotent stem cell model for cardiofaciocutaneous syndrome and uses thereof." This invention relates to an induced pluripotent stem cell (iPS) model specifically designed for cardiofaciocutaneous (CFC) syndrome. The patent outlines a method for producing the model and its applications in analyzing neural development associated with CFC syndrome. The research demonstrated that the CFC syndrome-derived iPS and embryonic body exhibited abnormal shapes and failed to differentiate into neurons. However, by treating the embryonic body with specific inhibitors, normal differentiation into neurons was achieved. This model can be effectively utilized in research focused on neural development in CFC syndrome.
Career Highlights
Kyu-Min Han is affiliated with the Korea Advanced Institute of Science and Technology, where he continues to push the boundaries of scientific research. His work has garnered attention for its innovative approach to understanding complex genetic conditions.
Collaborations
Kyu-Min Han collaborates with fellow researcher Yong-mahn Han, contributing to advancements in the field of stem cell research.
Conclusion
Kyu-Min Han's contributions to stem cell research, particularly through his patented work on cardiofaciocutaneous syndrome, highlight his role as an innovator in the scientific community. His research has the potential to significantly impact the understanding and treatment of this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
